These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26361945)

  • 1. Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation.
    Jeffs LS; Nitschke J; Tervaert JW; Peh CA; Hurtado PR
    Clin Rheumatol; 2016 Apr; 35(4):943-51. PubMed ID: 26361945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination.
    Duggal T; Segal P; Shah M; Carter-Monroe N; Manoharan P; Geetha D
    Am J Nephrol; 2013; 38(2):174-8. PubMed ID: 23941822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis.
    Tadema H; Kallenberg CG; Stegeman CA; Heeringa P
    PLoS One; 2011 Mar; 6(3):e17972. PubMed ID: 21437233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis.
    Sandin C; Eriksson P; Segelmark M; Skogh T; Kastbom A
    Clin Exp Immunol; 2016 May; 184(2):208-15. PubMed ID: 26762653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?
    Birck R; Kaelsch I; Schnuelle P; Flores-Suárez LF; Nowack R
    J Clin Rheumatol; 2009 Sep; 15(6):289-91. PubMed ID: 19734734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study.
    Hilhorst M; Arndt F; Joseph Kemna M; Wieczorek S; Donner Y; Wilde B; Thomas Epplen J; van Paassen P; Cohen Tervaert JW
    Arthritis Rheumatol; 2016 Jul; 68(7):1721-30. PubMed ID: 26866715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity: Does autoantigen complementarity underlie PR3-ANCA AAV?
    Preston G; Falk R
    Nat Rev Rheumatol; 2011 Jun; 7(8):439-40. PubMed ID: 21670769
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
    Holding S; Fisher VJ; Abuzakouk M
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission.
    Tadema H; Abdulahad WH; Lepse N; Stegeman CA; Kallenberg CG; Heeringa P
    Rheumatology (Oxford); 2011 Apr; 50(4):689-96. PubMed ID: 21149241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
    Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
    J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Jeffs LS; Peh CA; Jose MD; Lange K; Hurtado PR
    Nephrology (Carlton); 2015 May; 20(5):343-51. PubMed ID: 25656094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4.
    Wang C; Wang H; Chang DY; Hao J; Zhao MH; Chen M
    Arthritis Res Ther; 2015 Mar; 17(1):64. PubMed ID: 25889374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
    Almroth G; Berlin G; Andersson B; Hahn-Zoric M
    Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls.
    Cornec D; Berti A; Hummel A; Peikert T; Pers JO; Specks U
    J Autoimmun; 2017 Nov; 84():122-131. PubMed ID: 28870527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent pathogenetic advances in ANCA-associated vasculitis.
    Pendergraft WF; Nachman PH
    Presse Med; 2015 Jun; 44(6 Pt 2):e223-9. PubMed ID: 26033562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.